Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul-Aug;23(4):311-315.
doi: 10.4103/jisp.jisp_748_18.

Effects of recombinant human bone morphogenetic protein-2 compared to other biomaterials in the treatment of intrabony defects in periodontitis patients: A systematic review

Raghavendra Shrishail Medikeri  1 , Vinayak Venkoosa Meharwade  1 , Kumar Ankit Sinha  1
Affiliations
Review

Effects of recombinant human bone morphogenetic protein-2 compared to other biomaterials in the treatment of intrabony defects in periodontitis patients: A systematic review

Raghavendra Shrishail Medikeri et al. J Indian Soc Periodontol. 2019 Jul-Aug.

Abstract

Background: Bone morphogenetic proteins have a powerful osteoinductive capacity and have been used as a new adjunct to graft materials for bone regeneration. The objectives of this systematic review are to assess the amount of radiographic bone fill, clinical attachment level (CAL) gain, and reduction in pocket depth (PD) in patients with intrabony defects in periodontitis patients following the use of recombinant human bone morphogenetic protein-2 (rhBMP-2).

Materials and methods: Electronic bibliographic databases search of Medline, Science Direct, and Google Scholar was made from January 1980 to December 2017. Studies using rhBMP-2 to treat periodontal intrabony defects of the maxillary or mandibular region with follow-up period of at least 6 months were searched. Two reviewers performed the systematic review using the PRISMA Statement for reporting and the Cochrane risk-of-bias tool was used for quality assessment.

Results: It was found that rhBMP-2 showed statistically significant results with respect to radiographic defect resolution, CAL, and PD reduction at 9 months compared to open-flap debridement but showed statistically significant results only with respect to radiographic bone fill when compared with platelet-rich fibrin at 6 months.

Conclusion: The rhBMP-2 may provide a promising alternative to traditional grafting procedures therapy that can enhance periodontal regeneration in patients having intrabony defects. Due to limited human studies, it can be concluded that no definitive evidence exists to ascertain the effectiveness of rhBMP-2 in the treatment of intrabony defects in periodontal diseases.

Keywords: Bone morphogenetic proteins; intrabony defects; periodontal regeneration; recombinant human bone morphogenetic protein-2.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram (2009). n – Number of studies
Figure 2
Figure 2
Overall assessment of risk of bias in included studies
See this image and copyright information in PMC

References

    1. Ripamonti U, Renton L. Bone morphogenetic proteins and the induction of periodontal tissue regeneration. Periodontol 2000. 2006;41:73–87. - PubMed
    1. Hollinger JO, Uludag H, Winn SR. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev. 1998;31:303–18. - PubMed
    1. Wang EA. Bone morphogenetic proteins (BMPs): Therapeutic potential in healing bony defects. Trends Biotechnol. 1993;11:379–83. - PubMed
    1. Urist MR. Bone: Formation by autoinduction. Science. 1965;150:893–9. - PubMed
    1. Sudharsana A. Recombinant human bone morphogenetic protein 2/absorbable collagen sponge (rhBMP-2/ACS) in periodontal therapy – An overview. J Pharm Sci Res. 2015;7:1.

LinkOut - more resources